Add Company
Join Now

ILC Therapeutics Revenue and Competitors

License our Company Data API

Glasgow, UK

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • ILC Therapeutics's estimated annual revenue is currently $1.6M per year.(i)
  • ILC Therapeutics's estimated revenue per employee is $201,000

Employee Data

  • ILC Therapeutics has 8 Employees.(i)
  • ILC Therapeutics grew their employee count by -20% last year.

ILC Therapeutics's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
CEOReveal Email/Phone
3
Chief Operating OfficerReveal Email/Phone
4
Senior ScientistReveal Email/Phone
5
Laboratory TechnicianReveal Email/Phone
6
Research associateReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$64.5M32110%N/AN/A
#2
$25.5M1275%N/AN/A
#3
$115.6M5752%N/AN/A
#4
$21.7M1084%N/AN/A
#5
$44.8M2239%N/AN/A
#6
$15.1M75-67%N/AN/A
#7
$16.1MN/AN/AN/A
#8
$84.4M4200%N/AN/A
#9
$8.8M4410%N/AN/A
#10
$31M15428%N/AN/A
Add Company

What Is ILC Therapeutics?

ILC Therapeutics is a specialist UK-based developer of hybrid interferons, a new engineered drug class with improved therapeutic profiles, enabling broad applications across multiple indications. Hybrid interferons combine favourable attributes of specific natural interferon sub-types to produce novel drug candidates designed to deliver reduced toxicity and improved efficacy.\n\nILC Therapeutic’s platform approach has produced two first-in-class lead candidates, Alfacyte™ and Dermacyte™ focused on antiviral and dermatological indications respectively, which are progressing towards the clinic.

keywords:N/A

N/A

Total Funding

8

Number of Employees

$1.6M

Revenue (est)

-20%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$0.3M814%N/A
#2
$1.7M80%N/A
#3
$0.7M8-11%N/A
#4
$0.6M8-58%N/A
#5
$1.3M8-11%N/A